Table 1 Clinical and histopathological features
From: Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β
A II(n = 6) | A III(n = 12) | GBM(n = 55) | Control cortex/autopsy (n = 8) | Control cortex/surgical (n = 5) | |
|---|---|---|---|---|---|
Gender (m/f) | 4/2 | 7/5 | 33/22 | 5/3 | 3/2 |
Age (years)a | 34 (22–43) | 44.7 (33–51) | 56.5 (26–76) | 50 (30–72) | 54 (43–75) |
Location | - | ||||
Frontal | 5 | 3 | 18 | 4 | 2 |
Temporal | 1 | 3 | 15 | 1 | - |
Parietal | - | - | 4 | 5 | 2 |
Occipital | - | 1 | 3 | 1 | - |
Thalamus | - | - | 1 | - | - |
Parietooccipital | - | 2 | 3 | - | - |
Temporoccipital | - | 2 | 1 | - | 1 |
Temporoparietal | - | - | 1 | - | - |
Frontotemporal | - | 1 | 3 | - | - |
Frontoparietal | - | - | 1 | - | - |
Epilepsy | 6 | 7 | 29 | - | - |
Duration epilepsy (months) a | 6 (4–11) | 4.8 (1–9) | 6.5 (1–12) | - | - |